Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hypromellose-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulose 0.32% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose+phenylephrine 0.5/0.12% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose 0.3% eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hypromellose 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypotonic artificial tears eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulose 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose adverse reaction |
Causative agent (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose eye drops adverse reaction |
Causative agent (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to hypromellose |
Causative agent (attribute) |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose eye drops allergy |
Causative agent (attribute) |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxypropyl methylcellulose 0.32% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose+phenylephrine 0.5/0.12% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose 0.3% eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hypromellose 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypromellose- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydroxypropylmethylcellulose 1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropylmethylcellulose 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropylmethylcellulose in balanced salt solution 2% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypotonic artificial tears eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulose 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropylmethylcellulose 2% injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropylmethylcellulose 1.8% injection solution 1.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulose 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl methylcellulos 2.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxypropyl cellulose 5mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dexamethasone+hypromellose 0.1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and glutathione and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to hypromellose |
Causative agent (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose eye drops allergy |
Causative agent (attribute) |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
Has precise active ingredient |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
Has basis of strength substance (attribute) |
False |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 0.3% eye drops (product) |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 0.3% eye drops (product) |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 10 mg/mL eye drops |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 10 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hypromellose 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hypromellose 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dextran 70 and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextran 70 and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose and glutathione and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hypromellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextran 70 and hypromellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 3.2 mg/mL eye solution |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hypromellose 3.2 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dexamethasone and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dexamethasone and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hypromellose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |